Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results from the EXPEDITE study of Remodulin® induction prior to Orenitram® therapy to be presented at ATS Baseline patient data from the TETON studies of Tyvaso® Inhalation Solution in... | April 18, 2023
Data presented at AACR Annual Meeting support IMM-1-104's potential to address a broad population of patients with RAS mutant tumorsIMM-1-104 well tolerated with no dose limiting toxicities or... | April 18, 2023
MIAMI, FL / ACCESSWIRE / April 18, 2023 / Mark your calendars and push into high-gear this season. As the FORMULA 1 CRYPTO.COM MIAMI GRAND PRIX 2023 descends into the 305 city limits for its second consecutive
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)
The Covalis Capital hedge fund said on Monday it had presented an alternative list of candidates for the board of state-controlled utility Enel , in opposition to that put forward last week by the... | April 17, 2023